Claim
stringlengths 22
587
| Question
stringclasses 80
values | Evidence
stringclasses 634
values | Label
stringclasses 3
values |
|---|---|---|---|
Results on the use of hydroxychloroquine as a treatment for Covid-19 have shown no significant differences in health outcomes between the control group and patients who received the experimental drug. | does hydroxychloroquine treat COVID-19? | HCQ should be prescribed as a part of treatment for critically ill COVID-19 patients, with possible outcome of saving lives. | Refutes |
Results on the use of hydroxychloroquine as a treatment for Covid-19 have shown no significant differences in health outcomes between the control group and patients who received the experimental drug. | does hydroxychloroquine treat COVID-19? | The available evidence suggests that CQ or HCQ does not improve clinical outcomes in COVID-19. | Supports |
Results on the use of hydroxychloroquine as a treatment for Covid-19 have shown no significant differences in health outcomes between the control group and patients who received the experimental drug. | does hydroxychloroquine treat COVID-19? | There is theoretical, experimental, preclinical and clinical evidence of the effectiveness of chloroquine in patients affected with COVID-19. | Refutes |
Results on the use of hydroxychloroquine as a treatment for Covid-19 have shown no significant differences in health outcomes between the control group and patients who received the experimental drug. | does hydroxychloroquine treat COVID-19? | hydroxychloroquine with or without azithromycin showed benefits in positive-to-negative conversion of SARS-CoV-2 (odds ratio [OR], 1.95 [95% CI,0.19 to 19.73] and a reduction in progression rate (OR, 0.89 [95% CI, 0.58 to 1.37]), but without demonstrating any statistical significance. | Neutral |
The good news. Properly disinfecting our homes and commonly touched objects helps prevent the spread of all contagious diseases, including COVID-19. | Can vinegar help in preventing COVID-19? | As discussed in this review, till effective vaccines and treatments emerge, it is important to understand the scientific rationale of pandemic-mitigation strategies such as wearing facemasks and social distancing, and implement them. | Neutral |
The good news. Properly disinfecting our homes and commonly touched objects helps prevent the spread of all contagious diseases, including COVID-19. | Can vinegar help in preventing COVID-19? | Considering its potential benefits and high availability, acetic acid disinfection appears to be a promising adjunctive therapy in cases of non-severe COVID-19 and deserves further investigation. | Supports |
The good news. Properly disinfecting our homes and commonly touched objects helps prevent the spread of all contagious diseases, including COVID-19. | Can vinegar help in preventing COVID-19? | In Unani medicine, during an epidemic, apart from isolation and quarantine, three measures are of utmost importance, (i) purification of surroundings using certain herbal drugs as fumigants or sprays, (ii) health promotion and immune-modulation, and (iii) use of health-protecting drugs and symptom-specific drugs. Drugs such as loban (Styrax benzoides W. G. Craib), sandroos (Hymenaea verrucosa Gaertn.) za'fran (Crocus sativus L.), vinegar etc. are prescribed in various forms. | Supports |
The good news. Properly disinfecting our homes and commonly touched objects helps prevent the spread of all contagious diseases, including COVID-19. | Can vinegar help in preventing COVID-19? | Numerous clinical trials have been launched to identify effective treatments for COVID-19. Initial data from a placebo-controlled study suggest faster time to recovery in patients on remdesivir; it is now being evaluated in additional controlled studies. | Supports |
If you decide to engage in public activities, continue to protect yourself by practicing everyday preventive actions.; Keep these items on hand when venturing out: a mask, tissues, and a hand sanitizer with at least 60% alcohol, if possible. | How much impact do masks have on preventing the spread of the COVID-19? | Model simulations, using data relevant to COVID-19 dynamics in the US states of New York and Washington, suggest that broad adoption of even relatively ineffective face masks may meaningfully reduce community transmission of COVID-19 and decrease peak hospitalizations and deaths. | Supports |
If you decide to engage in public activities, continue to protect yourself by practicing everyday preventive actions.; Keep these items on hand when venturing out: a mask, tissues, and a hand sanitizer with at least 60% alcohol, if possible. | How much impact do masks have on preventing the spread of the COVID-19? | COVID-19, caused by SARS-CoV2 is a rapidly spreading global pandemic. Although precise transmission routes and dynamics are unknown, SARS-CoV2 is thought primarily to spread via contagious respiratory droplets. | Neutral |
If you decide to engage in public activities, continue to protect yourself by practicing everyday preventive actions.; Keep these items on hand when venturing out: a mask, tissues, and a hand sanitizer with at least 60% alcohol, if possible. | How much impact do masks have on preventing the spread of the COVID-19? | Depending on the region we analyse, we find that face masks reduced the cumulative number of registered Covid-19 cases between 2.3% and 13% over a period of 10 days after they became compulsory. Assessing the credibility of the various estimates, we conclude that face masks reduce the daily growth rate of reported infections by around 40%. | Supports |
If you decide to engage in public activities, continue to protect yourself by practicing everyday preventive actions.; Keep these items on hand when venturing out: a mask, tissues, and a hand sanitizer with at least 60% alcohol, if possible. | How much impact do masks have on preventing the spread of the COVID-19? | It would therefore be reasonable to suggest that consistent widespread use of face masks in the community could prevent further spread of the Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2). | Supports |
Blood clotting a significant cause of death in patients with COVID-19 | how do people die from the coronavirus? | Respiratory failure has been cited as the major cause of death | Refutes |
Blood clotting a significant cause of death in patients with COVID-19 | how do people die from the coronavirus? | The cause of most deaths has been acute pneumonia. | Refutes |
Blood clotting a significant cause of death in patients with COVID-19 | how do people die from the coronavirus? | Lack of personal protective equipment was cited as a common cause of death. | Refutes |
Blood clotting a significant cause of death in patients with COVID-19 | how do people die from the coronavirus? | Compared to the recovered group, more patients in the death group exhibited characteristics of advanced age, pre-existing comorbidities, dyspnea, oxygen saturation decrease, increased WBC count, decreased lymphocytes, and elevated CRP levels. | Supports |
But until we understand more about who is a carrier of COVID-19, the goal of wearing a mask should be to protect others from your own respiratory droplets. And any mask is better than no mask. | Does a surgical mask help avoid COVID-19? | Surgical mask partition reduces the risk of non-contact transmission in a golden Syrian hamster model for Coronavirus Disease 2019 (COVID-19) | Supports |
But until we understand more about who is a carrier of COVID-19, the goal of wearing a mask should be to protect others from your own respiratory droplets. And any mask is better than no mask. | Does a surgical mask help avoid COVID-19? | Evidence on mask effectiveness for respiratory infection prevention is stronger in health care than community settings. | Supports |
But until we understand more about who is a carrier of COVID-19, the goal of wearing a mask should be to protect others from your own respiratory droplets. And any mask is better than no mask. | Does a surgical mask help avoid COVID-19? | Respirators such as filtering face piece (FFP) 2 masks were designed to protect HCWs, while surgical masks were originally intended to protect patients (e.g., during surgery). | Supports |
But until we understand more about who is a carrier of COVID-19, the goal of wearing a mask should be to protect others from your own respiratory droplets. And any mask is better than no mask. | Does a surgical mask help avoid COVID-19? | Community mask use was possibly associated with decreased risk for SARS-CoV-1 infection in observational studies. | Supports |
The COVID-19 Treatment Guidelines Panel (the Panel) recommends against the use of chloroquine or hydroxychloroquine with or without azithromycin for the treatment of COVID-19 in hospitalized patients (AI). | does hydroxychloroquine treat COVID-19? | The available evidence suggests that CQ or HCQ does not improve clinical outcomes in COVID-19. | Supports |
The COVID-19 Treatment Guidelines Panel (the Panel) recommends against the use of chloroquine or hydroxychloroquine with or without azithromycin for the treatment of COVID-19 in hospitalized patients (AI). | does hydroxychloroquine treat COVID-19? | the use of hydroxychloroquine alone was associated with increased mortality in COVID-19 patients. | Supports |
The COVID-19 Treatment Guidelines Panel (the Panel) recommends against the use of chloroquine or hydroxychloroquine with or without azithromycin for the treatment of COVID-19 in hospitalized patients (AI). | does hydroxychloroquine treat COVID-19? | mortality rate was increased when the treatment was conducted with hydroxychloroquine. | Supports |
The COVID-19 Treatment Guidelines Panel (the Panel) recommends against the use of chloroquine or hydroxychloroquine with or without azithromycin for the treatment of COVID-19 in hospitalized patients (AI). | does hydroxychloroquine treat COVID-19? | The odds of mortality were significantly higher in patients treated with Hydroxychloroquine + Azithromycin than supportive care alone [2.34 (95% CI: 1.63, 3.34); I2 = 0%]. A pooled analysis of recently published studies suggests no additional benefit for reducing mortality in COVID-19 patients when Hydroxychloroquine is given as add-on to the standard care. | Supports |
Colloidal silver can cure COVID-19 | Does garlic protect against covid-19 | compounds derived from Allium sativum (garlic) have the potential to decrease the expression of proinflammatory cytokines and to reverse the immunological abnormalities to more acceptable levels. Allium sativum is suggested as a beneficial preventive measure before being infected with SARS-CoV-2 virus. | Refutes |
Colloidal silver can cure COVID-19 | Does garlic protect against covid-19 | In late December 2019 in Wuhan, China, several patients with viral pneumonia were identified as 2019 novel coronavirus (2019-nCoV). So far, there are no specific treatments for patients with coronavirus disease-19 (COVID-19), and the treatments available today are based on previous experience with similar viruses such as severe acute respiratory syndrome-related coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and Influenza virus. | Refutes |
Colloidal silver can cure COVID-19 | Does garlic protect against covid-19 | In conclusion, Allium sativum may be an acceptable preventive measure against COVID-19 infection to boost immune system cells and to repress the production and secretion of proinflammatory cytokines as well as an adipose tissue derived hormone leptin having the proinflammatory nature. | Refutes |
Now a days, due to staying indoors, it is possible that you will develop the deficiency of vitamin D. | Does Vitamin D impact COVID-19 prevention and treatment? | testing positive for COVID-19 was associated with increasing age(RR(age<50)=1.05,p<0.021;RR(age[]50)=1.02,p<0.064)), non-white race(RR=2.54,p<0.01) and being likely vitamin D deficient (deficient/treatment-not-increased:RR=1.77,p<0.02) as compared to likely vitamin D sufficient(not-deficient/treatment-not-decreased), with predicted COVID-19 rates in the vitamin D deficient group of 21.6%(95%CI[14.0%-29.2%] ) versus 12.2%(95%CI[8.9%-15.4%]) in the vitamin D sufficient group. | Neutral |
Now a days, due to staying indoors, it is possible that you will develop the deficiency of vitamin D. | Does Vitamin D impact COVID-19 prevention and treatment? | Several studies demonstrated the role of vitamin D in reducing the risk of acute viral respiratory tract infections and pneumonia. These include direct inhibition with viral replication or with anti-inflammatory or immunomodulatory ways. In the meta-analysis, vitamin D supplementation has been shown as safe and effective against acute respiratory tract infections. Thus, people who are at higher risk of vitamin D deficiency during this global pandemic should consider taking vitamin D supplements to maintain the circulating 25(OH)D in the optimal levels (75-125nmol/L). | Neutral |
Now a days, due to staying indoors, it is possible that you will develop the deficiency of vitamin D. | Does Vitamin D impact COVID-19 prevention and treatment? | A significant negative correlation (p=0.033) has been observed between mean vitamin D levels and COVID-19 cases per one million population in European countries. | Neutral |
Now a days, due to staying indoors, it is possible that you will develop the deficiency of vitamin D. | Does Vitamin D impact COVID-19 prevention and treatment? | In Middle East, the recovery rate (r= 0.267) and mortality rate (r= -0.217) showed a medium correlation. | Neutral |
in vivo preclinical results with favipiravir which indicate that antiviral efficacy against SARS-CoV-2 might only be achieved with a very high dose. | are there any drugs that work for SARS-CoV or SARS-CoV-2 in animals? | At this point, the data here presented on hydroxychloroquine either alone or combined with azithromycin (together with previously reported in vivo data in macaques and ferrets) provide no scientific basis for further use of the drug in humans. | Neutral |
in vivo preclinical results with favipiravir which indicate that antiviral efficacy against SARS-CoV-2 might only be achieved with a very high dose. | are there any drugs that work for SARS-CoV or SARS-CoV-2 in animals? | There is no therapeutic FDA-approved drug against SARS-CoV-2 infection, although a combination of anti-viral drugs is directly being practiced in some countries. | Neutral |
in vivo preclinical results with favipiravir which indicate that antiviral efficacy against SARS-CoV-2 might only be achieved with a very high dose. | are there any drugs that work for SARS-CoV or SARS-CoV-2 in animals? | Thus, our goal is to test the most active antivirals identified in adequate animal models infected with SARS-CoV-2, to add more information about possible in vivo efficacy. In turn, successful antivirals could be tested in clinical trials as treatments for infected patients, but also as pre-exposure prophylaxis to avoid novel infections until an effective and safe vaccine is developed. | Neutral |
in vivo preclinical results with favipiravir which indicate that antiviral efficacy against SARS-CoV-2 might only be achieved with a very high dose. | are there any drugs that work for SARS-CoV or SARS-CoV-2 in animals? | The results suggest the effectiveness of Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir as potent drugs against SARS-CoV-2 since they tightly bind to its RdRp. In addition, the results suggest guanosine derivative (IDX-184), Setrobuvir, and YAK as top seeds for antiviral treatments with high potential to fight the SARS-CoV-2 strain specifically. | Neutral |
Lockdowns and Mask Mandates Do Not Lead to Reduced COVID transmission rates or deaths | How much impact do masks have on preventing the spread of the COVID-19? | We recommend immediate mask wearing recommendations, official guidelines for correct use, and awareness campaigns to shift masking mindsets away from pure self-protection, towards aspirational goals of responsibly protecting one's community. | Refutes |
Lockdowns and Mask Mandates Do Not Lead to Reduced COVID transmission rates or deaths | How much impact do masks have on preventing the spread of the COVID-19? | Depending on the region we analyse, we find that face masks reduced the cumulative number of registered Covid-19 cases between 2.3% and 13% over a period of 10 days after they became compulsory. Assessing the credibility of the various estimates, we conclude that face masks reduce the daily growth rate of reported infections by around 40%. | Refutes |
Lockdowns and Mask Mandates Do Not Lead to Reduced COVID transmission rates or deaths | How much impact do masks have on preventing the spread of the COVID-19? | It would therefore be reasonable to suggest that consistent widespread use of face masks in the community could prevent further spread of the Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2). | Refutes |
Lockdowns and Mask Mandates Do Not Lead to Reduced COVID transmission rates or deaths | How much impact do masks have on preventing the spread of the COVID-19? | Our results suggest use of face masks by the general public is potentially of high value in curtailing community transmission and the burden of the pandemic. The community-wide benefits are likely to be greatest when face masks are used in conjunction with other non-pharmaceutical practices (such as social-distancing), and when adoption is nearly universal (nation-wide) and compliance is high. | Refutes |
young men with severe COVID-19 had mutations in the gene for a certain cell receptor. This receptor, some researchers suspect, grows scarcer as we age. | will SARS-CoV2 infected people develop immunity? | Distinguishing pre-existing and de novo antibody responses to SARS-CoV-2 will be critical for serology, seroprevalence and vaccine studies, as well as for our understanding of susceptibility to and natural course of SARS-CoV-2 infection. | Neutral |
young men with severe COVID-19 had mutations in the gene for a certain cell receptor. This receptor, some researchers suspect, grows scarcer as we age. | will SARS-CoV2 infected people develop immunity? | Based on animal experiments, already acquired data on other coronavirus types and plausibility assumptions, it can be assumed that seroconverted patients have an immunity of limited duration and only a very low risk of reinfection. | Neutral |
young men with severe COVID-19 had mutations in the gene for a certain cell receptor. This receptor, some researchers suspect, grows scarcer as we age. | will SARS-CoV2 infected people develop immunity? | The number of these epitopes and the prevalence of the common coronaviruses suggest that a large part of the world population has some degree of specific immunity against SARS-CoV-2 already, even without having been infected by that virus. | Neutral |
young men with severe COVID-19 had mutations in the gene for a certain cell receptor. This receptor, some researchers suspect, grows scarcer as we age. | will SARS-CoV2 infected people develop immunity? | The number of these epitopes and the prevalence of the common coronaviruses suggest that a large part of the world population has some degree of specific immunity against SARS-CoV-2 already, even without having been infected by that virus. | Neutral |
There is no correlation between Vitamin D levels and Covid-19 infection risk | Does Vitamin D impact COVID-19 prevention and treatment? | In Europe, there were no correlations for both recovery (r= 0.040) and mortality rate (r= -0.035). | Supports |
There is no correlation between Vitamin D levels and Covid-19 infection risk | Does Vitamin D impact COVID-19 prevention and treatment? | In Middle East, the recovery rate (r= 0.267) and mortality rate (r= -0.217) showed a medium correlation. | Refutes |
There is no correlation between Vitamin D levels and Covid-19 infection risk | Does Vitamin D impact COVID-19 prevention and treatment? | A principal defence against uncontrolled inflammation, and against viral infection in general, is provided by T regulatory lymphocytes (Tregs). Treg levels have been reported to be low in many COVID-19 patients and can be increased by vitamin D supplementation. Low vitamin D levels have been associated with an increase in inflammatory cytokines and a significantly increased risk of pneumonia and viral upper respiratory tract infections. Vitamin D deficiency is associated with an increase in thrombotic episodes, which are frequently observed in COVID-19. Vitamin D deficiency has been found to occur more frequently in patients with obesity and diabetes. These conditions are reported to carry a higher mortality in COVID-19. If vitamin D does in fact reduce the severity of COVID-19 in regard to pneumonia/ARDS, inflammation, inflammatory cytokines and thrombosis, it is our opinion that supplements would offer a relatively easy option to decrease the impact of the pandemic. | Refutes |
There is no correlation between Vitamin D levels and Covid-19 infection risk | Does Vitamin D impact COVID-19 prevention and treatment? | Several studies demonstrated the role of vitamin D in reducing the risk of acute viral respiratory tract infections and pneumonia. These include direct inhibition with viral replication or with anti-inflammatory or immunomodulatory ways. In the meta-analysis, vitamin D supplementation has been shown as safe and effective against acute respiratory tract infections. Thus, people who are at higher risk of vitamin D deficiency during this global pandemic should consider taking vitamin D supplements to maintain the circulating 25(OH)D in the optimal levels (75-125nmol/L). | Refutes |
A weaker immune system is one reason people with high blood pressure and other health problems are at higher risk for coronavirus. | will SARS-CoV2 infected people develop immunity? | The number of these epitopes and the prevalence of the common coronaviruses suggest that a large part of the world population has some degree of specific immunity against SARS-CoV-2 already, even without having been infected by that virus. | Neutral |
A weaker immune system is one reason people with high blood pressure and other health problems are at higher risk for coronavirus. | will SARS-CoV2 infected people develop immunity? | Thus both qualitative and quantitative features of B and T cell immunity to spike constitute informative biomarkers of the protective potential of novel SARS-CoV-2 vaccines. | Neutral |
A weaker immune system is one reason people with high blood pressure and other health problems are at higher risk for coronavirus. | will SARS-CoV2 infected people develop immunity? | we discovered evidence that SARS-CoV-2, along with related coronaviruses, used mutations to evade attack from the human immune system. Overall, we present an immunological resource for SARS-CoV-2 that could promote both therapeutic development and mechanistic research. | Neutral |
A weaker immune system is one reason people with high blood pressure and other health problems are at higher risk for coronavirus. | will SARS-CoV2 infected people develop immunity? | Based on animal experiments, already acquired data on other coronavirus types and plausibility assumptions, it can be assumed that seroconverted patients have an immunity of limited duration and only a very low risk of reinfection. | Neutral |
long-term exposure to PM2.5 air pollution, produced by sources including wildfires, power plants and vehicles, may make the coronavirus particularly deadly. | how does the coronavirus respond to changes in the weather | Results indicated that temperatures had a negative linear relationship with the number of confirmed cases. | Neutral |
long-term exposure to PM2.5 air pollution, produced by sources including wildfires, power plants and vehicles, may make the coronavirus particularly deadly. | how does the coronavirus respond to changes in the weather | Each 1 C rise of temperature was associated with a 4.8951% (t = 2.29, p = 0.0226) decrease in the number of daily cumulative confirmed cases of COVID-19 | Neutral |
long-term exposure to PM2.5 air pollution, produced by sources including wildfires, power plants and vehicles, may make the coronavirus particularly deadly. | how does the coronavirus respond to changes in the weather | temperature is the most influential parameter that reduces the growth at the rate of 13-17 cases/day with a 1C rise in temperature. | Neutral |
long-term exposure to PM2.5 air pollution, produced by sources including wildfires, power plants and vehicles, may make the coronavirus particularly deadly. | how does the coronavirus respond to changes in the weather | the temperature changes retarded the growth rate and found that -6.28{degrees}C and +14.51{degrees}C temperature is the favorable range for COVID-19 growth | Neutral |
Adequate Levels of Vitamin D Reduce Complications, Death Among COVID-19 Patients | Does Vitamin C impact COVID-19 prevention and treatment? | Some nutrients are actively involved in the proper functioning and strengthening of the human immune system against viral infections including dietary protein, omega-3 fatty acids, vitamin A, vitamin D, vitamin E, vitamin B1, vitamin B6, vitamin B12, vitamin C, iron, zinc, and selenium. Few studies were done on the effect of dietary components on prevention of COVID-19, but supplementation with these nutrients may be effective in improving the health status of patients with viral infections. | Supports |
Adequate Levels of Vitamin D Reduce Complications, Death Among COVID-19 Patients | Does Vitamin C impact COVID-19 prevention and treatment? | The majority of documents encouraged the consumption of fruits, vegetables, and whole grain foods. Thirty-one percent of the guidelines highlighted the importance of minerals and vitamins such as zinc and vitamins C, A, and D to maintain a well-functioning immune system. | Neutral |
Adequate Levels of Vitamin D Reduce Complications, Death Among COVID-19 Patients | Does Vitamin C impact COVID-19 prevention and treatment? | We identified a total of 17 patients who received IV vitamin C for COVID-19. The inpatient mortality rate in this series was 12% with 17.6% rates of intubation and mechanical ventilation. We noted a significant decrease in inflammatory markers, including ferritin and D-dimer, and a trend to decreasing FiO2 requirements, after vitamin C administration. | Neutral |
Adequate Levels of Vitamin D Reduce Complications, Death Among COVID-19 Patients | Does Vitamin C impact COVID-19 prevention and treatment? | Although COVID-19 can be rapidly diagnosed, efficient clinical treatment of COVID-19 remains unavailable, resulting in high fatality. | Neutral |
pets are not able to spread the COVID-19 virus. | Can animals spread COVID-19 to people? | Likewise, the S protein nucleotide sequence of the SARS-CoV-2 virus isolated in domestic animals and humans is identical, and the replication of the SARS-CoV-2 in cats is efficient. | Supports |
pets are not able to spread the COVID-19 virus. | Can animals spread COVID-19 to people? | Coronavirus disease-19 (COVID-19) caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is now a pandemic threat. This virus is supposed to be spread by human to human transmission. | Supports |
pets are not able to spread the COVID-19 virus. | Can animals spread COVID-19 to people? | ferrets and cats are highly susceptible to SARS-CoV-2 as infected by virus inoculation and can transmit the virus directly or indirectly by droplets or airborne routes. | Refutes |
pets are not able to spread the COVID-19 virus. | Can animals spread COVID-19 to people? | Covid19 origin and transmission to humans. | Neutral |
COVID-19 pandemic has helped drive gun violence and increase killings | How has the COVID-19 pandemic impacted violence in society, including violent crimes? | Numerous articles have reported a decrease in reports of domestic violence since quarantine began | Supports |
COVID-19 pandemic has helped drive gun violence and increase killings | How has the COVID-19 pandemic impacted violence in society, including violent crimes? | The novel coronavirus pandemic (hereafter COVID-19) is likely to have unprecedented impacts on the incidence and impacts of crime and violence globally. | Supports |
COVID-19 pandemic has helped drive gun violence and increase killings | How has the COVID-19 pandemic impacted violence in society, including violent crimes? | Domestic violence is a global public health problem. | Neutral |
COVID-19 Cases Drop in Warm Weather, But Not Much | how does the coronavirus respond to changes in the weather | temperature is the most influential parameter that reduces the growth at the rate of 13-17 cases/day with a 1C rise in temperature. | Supports |
COVID-19 Cases Drop in Warm Weather, But Not Much | how does the coronavirus respond to changes in the weather | Being a novel pandemic coronavirus version, it might be ongoing during summer conditions associated with higher air temperatures, low relative humidity and precipitation levels. | Refutes |
COVID-19 Cases Drop in Warm Weather, But Not Much | how does the coronavirus respond to changes in the weather | Each 1 C rise of temperature was associated with a 4.8951% (t = 2.29, p = 0.0226) decrease in the number of daily cumulative confirmed cases of COVID-19 | Supports |
COVID-19 Cases Drop in Warm Weather, But Not Much | how does the coronavirus respond to changes in the weather | Temperature is the most influential parameter that reduces the growth at the rate of 13-16 cases/day with a 1{degrees}C rise in temperature | Supports |
BCG: Can a vaccine from 1921 save lives from Covid-19? The vaccine was designed to stop tuberculosis, but there is some evidence it can protect against other infections as well. | can bcg vaccine cure covid-19 | It was seen that the countries with no universal BCG policy had a mean 1272.9 (median 795) cases per million and 80.7 deaths (median 18) per million population. | Supports |
BCG: Can a vaccine from 1921 save lives from Covid-19? The vaccine was designed to stop tuberculosis, but there is some evidence it can protect against other infections as well. | can bcg vaccine cure covid-19 | The adjusted rates ratio of COVID-19 confirmed cases for Current BCG vaccination vs. non-Current BCG vaccination was 0.339 (with 95% CI= (0.338,0.340)). | Supports |
BCG: Can a vaccine from 1921 save lives from Covid-19? The vaccine was designed to stop tuberculosis, but there is some evidence it can protect against other infections as well. | can bcg vaccine cure covid-19 | The non-specific beneficial effects of Bacille Calmette-Gurin (BCG) vaccination suggest that this vaccine might play a role in protecting individuals against severe coronavirus disease (COVID-19). | Supports |
BCG: Can a vaccine from 1921 save lives from Covid-19? The vaccine was designed to stop tuberculosis, but there is some evidence it can protect against other infections as well. | can bcg vaccine cure covid-19 | Universal immunization of BCG can provide great protection against the COVID-19 infection because the BCG vaccine gives broad protection against respiratory infections. | Supports |
surgical masks are effective barriers in preventing people from discharging infectious particles, at least quantity-wise. | Does a surgical mask help avoid COVID-19? | Such transmission could be reduced by surgical mask usage, especially when masks were worn by infected individuals. | Supports |
surgical masks are effective barriers in preventing people from discharging infectious particles, at least quantity-wise. | Does a surgical mask help avoid COVID-19? | To determine the risk of SARS-CoV-2 transmission by aerosols, to provide evidence on the rational use of masks, and to discuss additional measures important for the protection of healthcare workers from COVID-19. | Neutral |
surgical masks are effective barriers in preventing people from discharging infectious particles, at least quantity-wise. | Does a surgical mask help avoid COVID-19? | Surgical mask partition for challenged index or nave hamsters significantly reduced transmission to 25% (6/24, P=0.018). | Supports |
surgical masks are effective barriers in preventing people from discharging infectious particles, at least quantity-wise. | Does a surgical mask help avoid COVID-19? | Evidence on mask effectiveness for respiratory infection prevention is stronger in health care than community settings. | Supports |
it is possible to get COVID-19 by coming into contact with infected particles that can survive on surfaces for days or weeks. That led people to vigorously wipe down their light switches, scrub their groceries, and horde cleaning supplies. | touching a contaminated surface will not make you sick | Human Coronavirus 229E Remains Infectious on Common Touch Surface Materials | Supports |
it is possible to get COVID-19 by coming into contact with infected particles that can survive on surfaces for days or weeks. That led people to vigorously wipe down their light switches, scrub their groceries, and horde cleaning supplies. | touching a contaminated surface will not make you sick | Nonfabric surface materials were found to be much more favorable in the indirect contact transmission for RSV and rhinovirus than fabric surface materials. | Supports |
it is possible to get COVID-19 by coming into contact with infected particles that can survive on surfaces for days or weeks. That led people to vigorously wipe down their light switches, scrub their groceries, and horde cleaning supplies. | touching a contaminated surface will not make you sick | Frequent touching of contaminated surfaces in public areas is therefore a potential route of SARS-CoV-2 transmission. | Supports |
it is possible to get COVID-19 by coming into contact with infected particles that can survive on surfaces for days or weeks. That led people to vigorously wipe down their light switches, scrub their groceries, and horde cleaning supplies. | touching a contaminated surface will not make you sick | The risk of transmission via touching contaminated paper is low. | Refutes |
Respiratory failure is a Common Cause of Death in Critically Ill Coronavirus Patients | how do people die from the coronavirus? | Lack of personal protective equipment was cited as a common cause of death. | Refutes |
Respiratory failure is a Common Cause of Death in Critically Ill Coronavirus Patients | how do people die from the coronavirus? | The cause of most deaths has been acute pneumonia. | Supports |
Respiratory failure is a Common Cause of Death in Critically Ill Coronavirus Patients | how do people die from the coronavirus? | Respiratory failure has been cited as the major cause of death | Supports |
Respiratory failure is a Common Cause of Death in Critically Ill Coronavirus Patients | how do people die from the coronavirus? | Compared to the recovered group, more patients in the death group exhibited characteristics of advanced age, pre-existing comorbidities, dyspnea, oxygen saturation decrease, increased WBC count, decreased lymphocytes, and elevated CRP levels. | Supports |
It's a low risk to get covid-19 by groceries and packages that we have delivered, but it's possible that if someone is delivering a package to your house and they are sick, that may be a route for transmission. | touching a contaminated surface will not make you sick | The most common coronaviruses may well survive or persist on surfaces for up to one month. | Neutral |
It's a low risk to get covid-19 by groceries and packages that we have delivered, but it's possible that if someone is delivering a package to your house and they are sick, that may be a route for transmission. | touching a contaminated surface will not make you sick | Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), responsible for the COVID-19 pandemic, is transmitted by person-to-person contact, via airborne droplets, or through contact with contaminated surfaces. | Supports |
It's a low risk to get covid-19 by groceries and packages that we have delivered, but it's possible that if someone is delivering a package to your house and they are sick, that may be a route for transmission. | touching a contaminated surface will not make you sick | Surfaces near patients hospitalized with respiratory infections were frequently contaminated by pathogens, with Klebsiella pneumoniae being most common, highlighting the potential for transmission of respiratory pathogens via surfaces. | Refutes |
It's a low risk to get covid-19 by groceries and packages that we have delivered, but it's possible that if someone is delivering a package to your house and they are sick, that may be a route for transmission. | touching a contaminated surface will not make you sick | Contacting contaminated nonfabric surfaces may pose an indirect contact risk up to three orders of magnitude higher than that of contacting contaminated fabric surfaces. | Refutes |
the coronavirus hasn't been bioengineered | what is the origin of COVID-19 | This paper investigates the COVID-19 virus origin by using artificial intelligence (AI) and raw genomic sequences of the virus. | Neutral |
the coronavirus hasn't been bioengineered | what is the origin of COVID-19 | However, the source(s) and transmission routine(s) of SARSCoV2 remain elusive' (1). | Neutral |
the coronavirus hasn't been bioengineered | what is the origin of COVID-19 | Recent research results suggest that bats or pangolins might be the original hosts for the virus based on comparative studies using its genomic sequences. | Supports |
the coronavirus hasn't been bioengineered | what is the origin of COVID-19 | Zhou et al (1) mentioned that 'Direct contact with intermediate host animals or consumption of wild animals was suspected to be the main route of SARSCoV2 transmission. | Supports |
The coronavirus that causes COVID-19 mainly spreads from person to person. | touching a contaminated surface will not make you sick | Frequent touching of contaminated surfaces in public areas is therefore a potential route of SARS-CoV-2 transmission. | Refutes |
The coronavirus that causes COVID-19 mainly spreads from person to person. | touching a contaminated surface will not make you sick | In this new study, human coronavirus 229E was rapidly inactivated on a range of copper alloys (within a few minutes for simulated fingertip contamination) and Cu/Zn brasses were very effective at lower copper concentration. | Neutral |
The coronavirus that causes COVID-19 mainly spreads from person to person. | touching a contaminated surface will not make you sick | It was found that 83% and 77% of the bedside surfaces of MRSA-positive and MRSA-negative patients respectively were contaminated with staphylococci at 08:00 hours, and that the staphylococcal concentrations increased by 80% at 1200 h over a 4-hour period with routine ward and clinical activities. | Neutral |
The coronavirus that causes COVID-19 mainly spreads from person to person. | touching a contaminated surface will not make you sick | Our findings of extensive viral RNA contamination of surfaces and air across a range of acute healthcare settings in the absence of cultured virus underlines the potential risk from surface and air contamination in managing COVID-19, and the need for effective use of PPE, social distancing, and hand/surface hygiene. | Refutes |
COVID-19 symptoms can sometimes persist for months | are heart complications likely in patients with COVID-19? | Cardiovascular complications were mainly observed in the confirmed COVID-19+group, consisting of heart failure (9%), palpitations/arrhythmias (3%), stroke/TIA (3%) and pulmonary hypertension (3%). Cardiovascular symptoms such as chest pain (1%), myocardial injury (1%) and pericardial effusion (1%) were also recorded. | Neutral |
COVID-19 symptoms can sometimes persist for months | are heart complications likely in patients with COVID-19? | Myocardial injury is significantly associated with fatal outcome of COVID-19, while the prognosis of patients with underlying CVD but without myocardial injury is relatively favorable. Myocardial injury is associated with cardiac dysfunction and arrhythmias. Inflammation may be a potential mechanism for myocardial injury. | Neutral |
End of preview. Expand
in Dataset Viewer.
README.md exists but content is empty.
- Downloads last month
- 32